Use of the polymerase chain reaction for typing allelic variants of the human HLA-DQA1 by hybridization with oligonucleotide probes, specific for specific alleles]

Class II HLA molecules are the most useful markers for susceptibility to different autoimmune diseases, including insulin-dependent diabetes mellitus (IDDM) and rheumatoid arthritis (RA). Polymerase chain reaction and hybridization with a set of allele-specific oligonucleotide have been used for analysis of allelic sequence variation. The analysis of frequencies of HLA-DQA1 alleles among 10 patients of the russian population revealed a uneven distribution. We have developed a method for preparing non-radioactive oligonucleotide probes with terminal deoxynucleotidyl transferase and Bio-11-dUTP. Comparison of biotinylated and 32P-labeled hybridization probes gave the same sensitivity for HLA-DQA1 typing of amplified DNA. Amplification of the HLA-DQA1 gene has been successful on 10 pg of total DNA. This amount of DNA is close to the amount of DNA in a single cell. Alternatively, HLA-DQA1 typing could be based on the analysis of buccal cells of saliva that would avoid the problem of individuals who object to giving blood samples.     

Interaction of bromophenol blue with serum albumin: criteria for using dyes for assessing the state and quantity of protein

The optical properties of the complexes of the pH-dependent dye bromophenol blue (BPB) with human serum albumin were investigated by the spectrophotometric method. The solvatochromic longwave displacement of bound BPB-2 absorption and BPB-1/BPB-2 redistribution were shown to form the optical signal of complexes. Because of the distortion of the bound BPB-2 signal its quantity was determined as delta A630 = A630 - A660 and the use of lambda max as structural parameter was limited to low pH less than or equal to 3. The conclusion was made that BPB is inapplicable as a structural probe on account of low structural dependence of delta A630 and pH-limitation of lambda max used. The maximal absorption delta Amax = Amax - A660 and its structural independence were obtained in the region of 70-100% occupation of the dye-binding centers of the protein. It is the optimal conditions for the quantitative determination of protein. After maximal dye binding (15-16 molecules of BPB per 1 molecule of albumin) the aggregation and precipitation of the complexes occurred.     

Characteristics of the action of the influenza virus on the microcirculatory vessels in an experiment

The dynamic light-optic and electron microscopic examination of the organs of experimental animals with the influenza infection have revealed the most pronounced pathology in vessels of the lung and brain microcirculation. The early developing perivascular edema around capillaries which is induced by an increase in the transcellular transport without a disturbance of the dense contact integrity is observed in the brain tissue. Variations in the lung microvessels manifested in a rise of the pinocytosis activity of endothelial cells, in a change of the luminal surface profile and damage of the supermembrane layer. A reversible aggregation of plate and erythrocytes was observed in the lung and brain microvessel lumen at early periods. The revealed changes, including the main of them--microvessel permeability disturbance, are associated with the dynamics of the concentration of the influenza virus and its complexes with antibodies in the organs under study.     

Morphometric findings in the microcirculatory bed of the sigmoid serosa during the fetal period in man

During fetal life, formation and arrangement of the microcirculatory bed in the serous membrane of the sigmoid colon correspond to the growth and functioning of the latter at different stages of ontogenesis. Two periods in the development of the microcirculatory bed of the serous membrane of the sigmoid colon are revealed: the first period coincides with the first half of the fetal development when capillary growth is considerable, i.e. with the growth of metabolic part in the microcirculatory bed; the second period coincides with the second half of the fetal development when intensified growth of the sigmoid portion of the large intenstine and its transport sections in the microcirculatory bed (arterioles, precapillaries, postcapillaries, venules) are observed.     

New methodical approach to the study of platelet aggregation in vitro

A new approach to the investigation of the kinetics of platelet aggregation is described. The method is based on the analysis of light transmission fluctuations produced on the changes in the number of platelets in optical channel. The relative dispersion of the fluctuations of transmitted light intensity was used as a parameter to estimate the degree of platelet aggregation. Application of this method for the analysis of platelet aggregation permits to get new information about this process.     

Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry

Human immunodeficiency virus type 1 (HIV-1) entry is mediated by the consecutive interaction of the envelope glycoprotein gp120 with CD4 and a coreceptor such as CCR5 or CXCR4. The CCR5 coreceptor is used by the most commonly transmitted HIV-1 strains that often persist throughout the course of infection. Compounds targeting CCR5-mediated entry are a novel class of drugs being developed to treat HIV-1 infection. In this study, we have identified the mechanism of action of two inhibitors of CCR5 function, SCH-350581 (AD101) and SCH-351125 (SCH-C). AD101 is more potent than SCH-C at inhibiting HIV-1 replication in primary lymphocytes, as well as viral entry and gp120 binding to cell lines. Both molecules also block the binding of several anti-CCR5 monoclonal antibodies that recognize epitopes in the second extracellular loop of CCR5. Alanine mutagenesis of the transmembrane domain of CCR5 suggests that AD101 and SCH-C bind to overlapping but nonidentical sites within a putative ligand-binding cavity formed by transmembrane helices 1, 2, 3, and 7. We propose that the binding of small molecules to the transmembrane domain of CCR5 may disrupt the conformation of its extracellular domain, thereby inhibiting ligand binding to CCR5.